A surge in the share price of semiconductor giant Arm Holdings in recent weeks means the US-listed firm is now worth more than all but two FTSE-100 companies (Shell and AstraZeneca), says Matthew Field in The Telegraph. Its value has more than doubled in 2024. Arm designs “critical technology
Arm gains muscle
Feb 16, 2024
2 minutes
You’re reading a preview, subscribe to read more.
Start your free 30 days